CELH
Celsius Holdings, Inc.
CELH has the edge over KR overall, supported by stronger valuation and stronger fundamentals.
KR
The Kroger Co.
KR has slightly lower modeled downside risk, despite its lower overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
KR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Stable |
KR's revenue, profitability, cash flow and balance sheet are all currently stable.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over KR in the historical PE scenario, which offers more potential upside but is not a forecast.
KR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $69.81 | — |
| Cheap | 14x | $25.04 | -64% |
| Fair | 17x | $31.79 | -54% |
| Expensive | 32x | $59.31 | -15% |
| Current | 38x | $69.81 | — |
Historical ranges are pointers, not guarantees.
KR's PE is in its expensive range at 38x. If earnings grow as analysts expect, today's price would be 13x next year's earnings, in its cheap range.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over KR on the outlook, with more favorable profitability expectations.
KR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for KR, with profitability holding steady.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
KR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.50 | +197% |
| Q3 2026 | $1.85 | -53% |
| Q2 2026 | $1.71 | -53% |
| Q1 2026 | $1.54 | -58% |
| Q4 2025 | $1.08 | -71% |
| Q3 2025 | $3.94 | +3.1% |
| Q2 2025 | $3.67 | +25% |
| Q1 2025 | $3.67 | +24% |
| Q4 2024 | $3.78 | +48% |
KR has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over KR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over KR on profitability, with a higher operating margin.
KR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $34.6B | +2% |
| Q2 2026 | $46.1B | +2.2% |
| Q1 2026 | $34.7B | +1.2% |
| Q4 2025 | $33.9B | +0.7% |
| Q3 2025 | $33.9B | +0.1% |
| Q2 2025 | $45.1B | -0.3% |
| Q1 2025 | $34.3B | -7.4% |
| Q4 2024 | $33.6B | -1% |
KR's revenue grew through 2022 and has held roughly level since: $34.6B last quarter, up 2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.8% | +0.3 points |
| Q2 2026 | 3% | +0.1 points |
| Q1 2026 | 3.6% | +0.9 points |
| Q4 2025 | -4.5% | -7 points |
| Q3 2025 | 2.5% | +0.1 points |
| Q2 2025 | 2.9% | +0.1 points |
| Q1 2025 | 2.7% | -0.6 points |
| Q4 2024 | 2.5% | -0.2 points |
KR's operating margin was 2.8% last quarter, about level with the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the edge over KR on cash flow, with more consistent year-over-year improvement.
KR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $167M | -73% |
| Q2 2026 | $481M | -56% |
| Q1 2026 | $1.7B | +228% |
| Q3 2025 | $615M | +149% |
| Q2 2025 | $1.1B | +6.5% |
| Q1 2025 | $520M | -44% |
| Q3 2024 | $247M | -57% |
| Q2 2024 | $1B | -43% |
KR still generates free cash flow, though less than at its 2020 peak: $2.4B over the past year.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
KR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 2.4x | Moderate |
| Q1 2026 | 2.4x | Moderate |
| Q4 2025 | 2.4x | Moderate |
| Q2 2025 | 1.6x | Healthy |
| Q1 2025 | 1.7x | Healthy |
| Q4 2024 | 1.0x | Very low |
| Q2 2024 | 1.2x | Healthy |
| Q1 2024 | 1.3x | Healthy |
KR's net debt is about 2.4 years of its operating earnings (EBITDA), up from 1.7 years a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
KR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.5 | Neutral |
| Stochastic | 84.0 | Overbought |
KR's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH has the edge over KR on valuation relative to its sector.
KR PE vs Consumer Defensive Sector
| Metric | KR | Sector median | Relative |
|---|---|---|---|
| PE | 38x | 19x | 94% above |
| PE % | 92 | 18 | 74 pts above |
KR is trading at 38x earnings, a 94% premium to the Consumer Defensive sector's median of 19x.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
KR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $64.3 | 8.6% above |
| 20 week MA | $60.6 | 15% above |
| 50 week MA | $63.9 | 9.3% above |
| 100 week MA | $65.4 | 6.7% above |
| 200 week MA | $57.7 | 21% above |
KR has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
KR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.8 | $31.5 | +9.6% |
| 2021 | $31.5 | $43.2 | +37% |
| 2022 | $43.2 | $45.9 | +6.2% |
| 2023 | $45.9 | $45.7 | -0.4% |
| 2024 | $45.7 | $62.3 | +36% |
| 2025 | $62.3 | $63.3 | +1.5% |
| 2026 YTD | $63.3 | $69.8 | +10% |
KR has the edge over CELH on returns for 2026, with the stronger performance.